Q15109 (RAGE_HUMAN) Homo sapiens (Human)
Advanced glycosylation end product-specific receptor UniProtKBInterProSTRINGInteractive Modelling
404 aa; Sequence (Fasta) ; (Isoform 2; Isoform 3; Isoform 4; Isoform 5; Isoform 6; Isoform 7; Isoform 8; Isoform 9; Isoform 10);
1 identical sequence: Homo sapiens: A0A1U9X785
Available Structures
31 Experimental Structures
| Description | PDB ID | Oligo-state | Range | Seq id (%) | Ligands | |
|---|---|---|---|---|---|---|
| Crystal structure of the human RAGE ectodomain (VC1C2 fragment) in complex with human S100A6 |
Heteromer P06703; | 100 | 14×ZN; 10×CL; 6×ACT; 4×CA; | |||
| Crystal structure of the human RAGE ectodomain (fragment VC1C2) in complex with mouse S100A6 |
Heteromer P14069; | 100 | 6×ZN; 6×CL; 7×ACT; 2×CA; | |||
| The RAGE and HMGB1 complex |
Heteromer P09429; | 100 | ||||
| Structure of CEL-PEP-RAGE V domain complex |
Heteromer P02769; | 100 | ||||
| Structural Insights into Calcium Bound S100P - V Domain of the receptor for advanced glycation end … |
Heteromer P25815; | 100 | ||||
| Interaction of Human S100A6 (C3S) with V domain of Receptor for Advanced Glycation End products (RA… |
Heteromer P06703; | 100 | ||||
| RAGEC2-S100A13 tetrameric complex |
Heteromer Q99584; | 100 | ||||
| X-ray structure of Ca(2+)-S100B with human RAGE-derived W72 peptide |
Heteromer P04271; | 100 | 4×CA; 6×GOL; | |||
| X-ray structure of Ca(2+)-S100B with human RAGE-derived W61 peptide |
Heteromer P04271; | 100 | 4×CA; | |||
| Receptor for Advanced Glycation End Products VC1 domain in complex with 3-(3-((4-(4-carboxyphenoxy)… | homo-4-mer | 100 | 14×ACT; 4×CL; 4×V74; | |||
| Receptor for Advanced Glycation End Products VC1 domain in complex with 3-(3-(((3-(4-Carboxyphenoxy… | homo-4-mer | 100 | 8×ACT; 4×CL; 8×V6Y; | |||
| Receptor for Advanced Glycation End Products VC1 domain in complex with Fragment 5 | homo-4-mer | 100 | 18×ACT; 4×CL; 14×V6V; | |||
| Receptor for Advanced Glycation End Products VC1 domain in complex with Fragment 1 | homo-4-mer | 100 | 14×ACT; 4×CL; 4×V6M; | |||
| Receptor for Advanced Glycation End Products VC1 domain in complex with Fragments 1 & 11 | homo-4-mer | 100.0 | 12×ACT; 4×V6M; 6×V6P; 4×CL; | |||
| Receptor for Advanced Glycation End Products VC1 domain in complex with Fragment 11 | homo-4-mer | 100.0 | 14×ACT; 4×CL; 6×V6P; | |||
| RAGE is a nucleic acid receptor that promotes inflammatory responses to DNA. | homo-2-mer | 100 | ||||
| RAGE recognizes nucleic acids and promotes inflammatory responses to DNA | homo-2-mer | 100 | 4×EDO; | |||
| Receptor for Advanced Glycation End Products VC1 domain in complex with 3-(3-(((3-(4-Carboxyphenoxy… | homo-2-mer | 100 | 6×ACT; 2×CL; 8×Y6S; | |||
| Receptor for Advanced Glycation End Products VC1 domain in complex with 3-(3-((4-(4-carboxyphenoxy)… | homo-2-mer | 100.0 | 6×Y6P; 5×ACT; 1×CL; | |||
| Crystal structure of human rage ligand-binding domain | monomer | 100 | 1×ACT; 4×ZN; | |||
| Refinement of RAGE-DNA complex in 3S59 without DNA | monomer | 100 | ||||
| Refinement of RAGE-DNA complex in 3S58 without DNA | monomer | 100 | ||||
| Crystal structure of the full-length human RAGE extracellular domain (VC1C2 fragment) | monomer | 100 | ||||
| Crystal Structure of Human Receptor for Advanced Glycation Endproducts (RAGE) | monomer | 100 | 1×GLC; 1×SO4; | |||
| Receptor for Advanced Glycation End Products VC1 domain in complex with Fragments 1 & 13 | monomer | 100 | 2×ACT; 2×V6S; 1×V6M; | |||
| Crystal structure of the human RAGE VC1 fragment in space group P62 | monomer | 100 | 1×NA; | |||
| Receptor for Advanced Glycation End Products (RAGE) Specifically Recognizes Methylglyoxal Derived A… | monomer | 100 | 1×IOR; | |||
| Solution Structure of Variable-type Domain of Human Receptor for Advanced Glycation Endproducts | monomer | 100 | ||||
| Solution structure of the third ig-like domain from human Advanced glycosylation end product-specif… | monomer | 100 | ||||
| Structure of the C-terminal Domain of RAGE and Its Inhibitor | monomer | 93.75 | 1×RQV; | |||
| Solution Structure of C-terminal RAGE (ctRAGE) | monomer | 93.33 | ||||
3 SWISS-MODEL models
| Template | Oligo-state | QMEAN | Range | Ligands | Trg-Tpl Seq id (%) | |
|---|---|---|---|---|---|---|
| 4p2y.2.A | monomer | 0.80 | 100.00 | |||
| 4lp5.2.A | monomer | 0.77 | 100.00 | |||
| 8i9m.1.B | monomer | 0.53 | 100.00 | |||
22 SWISS-MODEL models built on isoform sequence
| Isoform | Template | Oligo-state | QMEAN | Range | Ligands | Trg-Tpl Seq id (%) | |
|---|---|---|---|---|---|---|---|
| Isoform 2 | 4ybh.1.C | monomer | 0.76 | 1×ZN; | 91.12 | ||
| Isoform 2 | 4lp5.2.A | monomer | 0.73 | 91.12 | |||
| Isoform 3 | 4ybh.1.C | monomer | 0.81 | 1×ZN; | 100.00 | ||
| Isoform 3 | 4lp5.2.A | monomer | 0.79 | 100.00 | |||
| Isoform 4 | 4ybh.1.C | monomer | 0.75 | 1×ZN; | 98.01 | ||
| Isoform 4 | 4lp5.2.A | monomer | 0.73 | 98.01 | |||
| Isoform 5 | 2mov.1.A | monomer | 0.66 | 93.68 | |||
| Isoform 6 | 4p2y.2.A | monomer | 0.75 | 98.33 | |||
| Isoform 6 | 4lp5.2.A | monomer | 0.74 | 98.33 | |||
| Isoform 6 | 4oi7.1.A | homo-2-mer | 0.71 | 100.00 | |||
| Isoform 7 | 4p2y.2.A | monomer | 0.79 | 97.89 | |||
| Isoform 7 | 4lp5.2.A | monomer | 0.76 | 97.89 | |||
| Isoform 7 | 4oi7.1.A | homo-2-mer | 0.75 | 100.00 | |||
| Isoform 8 | 4ybh.1.C | monomer | 0.77 | 1×ZN; | 89.75 | ||
| Isoform 8 | 4lp5.2.A | monomer | 0.74 | 89.75 | |||
| Isoform 8 | 6u8d.1.C | monomer | 0.51 | 12.11 | |||
| Isoform 9 | 4ybh.1.C | monomer | 0.71 | 1×ZN; | 90.78 | ||
| Isoform 9 | 4lp5.2.A | monomer | 0.69 | 90.78 | |||
| Isoform 10 | 4p2y.2.A | monomer | 0.80 | 100.00 | |||
| Isoform 10 | 4lp5.2.A | monomer | 0.78 | 100.00 | |||
| Isoform 10 | 8i9m.1.B | monomer | 0.53 | 100.00 | |||
| Isoform 10 | 8dnn.1.C | monomer | 0.51 | 12.63 | |||